Hyman Phelps and McNamara
 
Firm News
 

Bob Dormer is a panelist ACI Orphan Drugs and Rare Diseases Conference
November 28 - 29, 2012

Bob Dormer is a panelist for the session on "Pre-Conference Intensive Deep-Dive into the Orphan Drug Act: Demystifying the Designation Process and Discovering the Accompanying Incentives" at the ACI Orphan Drugs and Rare Diseases Conference

Hyatt Regency
Boston, MA

Click here for more information